Research ArticleArticle
Metabolic profiling of the novel HIF2α inhibitor PT2385 in vivo and in vitro
Cen Xie, Xiaoxia Gao, Dongxu Sun, Youbo Zhang, Kristopher W Krausz, Xuemei Qin and Frank Gonzalez
Drug Metabolism and Disposition January 23, 2018, dmd.117.079723; DOI: https://doi.org/10.1124/dmd.117.079723
Cen Xie
1 National Cancer Institute;
Xiaoxia Gao
2 Shanxi University;
Dongxu Sun
1 National Cancer Institute;
Youbo Zhang
1 National Cancer Institute;
Kristopher W Krausz
1 National Cancer Institute;
Xuemei Qin
2 Shanxi University;
Frank Gonzalez
3 NCI, NIH
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Metabolic profiling of the novel HIF2α inhibitor PT2385 in vivo and in vitro
Cen Xie, Xiaoxia Gao, Dongxu Sun, Youbo Zhang, Kristopher W Krausz, Xuemei Qin and Frank Gonzalez
Drug Metabolism and Disposition January 23, 2018, dmd.117.079723; DOI: https://doi.org/10.1124/dmd.117.079723
Research ArticleArticle
Metabolic profiling of the novel HIF2α inhibitor PT2385 in vivo and in vitro
Cen Xie, Xiaoxia Gao, Dongxu Sun, Youbo Zhang, Kristopher W Krausz, Xuemei Qin and Frank Gonzalez
Drug Metabolism and Disposition January 23, 2018, dmd.117.079723; DOI: https://doi.org/10.1124/dmd.117.079723
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement